{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:02:51Z","timestamp":1791475371355,"version":"4.3.4"},"reference-count":115,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Growth Hormone Research Society"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Long-acting growth hormone (LAGH) preparations have moved from development to routine clinical use over the past decade. Several products are now approved for paediatric growth hormone deficiency (GHD), selected non-GHD short-stature indications, and, in some regions, for adult GHD. The Growth Hormone Research Society convened an international workshop in October 2025 to reappraise the evidence base and refine clinical recommendations. Currently, data are available for up to 7 years of LAGH treatment in over 8000 individuals. This remains substantially shorter and smaller than for daily GH. Across preparations, short- to mid-term efficacy appears comparable to daily somatropin, provided dosing is individualized and monitored appropriately. Approvals and pivotal trials include both treatment initiation and switching from daily GH, depending on product and regional label. No new major safety signals have been identified in trials and real-world reports, although data on BMI trajectories require further evaluation. Injection-site reactions remain the most frequent adverse event and vary by formulation. Anti-drug antibodies have been observed, yet evidence suggests they have limited clinical impact. Effects on glucose metabolism resemble those of daily therapy, but metabolically, high-risk groups are under-represented in studies. Among cancer survivors, data on tumour recurrence and second neoplasms with LAGH are not yet available. Recommendations and practice points emphasized careful patient selection and counselling, product-specific dosing, and insulin-like growth factor-I (IGF-I) monitoring. Urgent knowledge gaps include transition care, long-term efficacy, adherence, and safety in cancer survivors. Well-resourced registries are essential for addressing these gaps and supporting safe, effective, and patient-centred use of LAGH.<\/jats:p>","DOI":"10.1093\/ejendo\/lvag167","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:07:57Z","timestamp":1788250077000},"page":"R73-R96","source":"Crossref","is-referenced-by-count":1,"title":["Long-acting growth hormone: an updated Growth Hormone Research Society consensus statement"],"prefix":"10.1093","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8667-0296","authenticated-orcid":false,"given":"Katharina","family":"Schilbach","sequence":"first","affiliation":[{"name":"Medizinische Klinik und Poliklinik IV, LMU Klinikum, Ludwig-Maximilians-Universit\u00e4t , Munich 80336 ,","place":["Germany"]},{"name":"Deggendorf Institute of Technology, Faculty of Applied Healthcare Sciences , Deggendorf 94469 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1225-4537","authenticated-orcid":false,"given":"Peter","family":"Clayton","sequence":"additional","affiliation":[{"name":"Developmental Biology & Medicine, Faculty of Biology, Medicine & Health, University of Manchester , Manchester M13 9PL ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6024-9236","authenticated-orcid":false,"given":"Nidhi","family":"Agrawal","sequence":"additional","affiliation":[{"name":"NYU Langone Medical Center, Division of Endocrinology Diabetes and Metabolism , New York, NY 10017 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8424-558X","authenticated-orcid":false,"given":"Mai C","family":"Arlien-S\u00f8borg","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine, Aarhus University Hospital , Aarhus 8200 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2398-9520","authenticated-orcid":false,"given":"Philippe F","family":"Backeljauw","sequence":"additional","affiliation":[{"name":"Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine , Cincinnati, OH 45229 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4359-4622","authenticated-orcid":false,"given":"Beverly M K","family":"Biller","sequence":"additional","affiliation":[{"name":"Neuroendocrine and Pituitary Tumor Clinical Center, Massachusetts General Hospital , Boston, MA 02114 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7285-7941","authenticated-orcid":false,"given":"Cesar L","family":"Boguszewski","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Endocrine Division (SEMPR), Federal University of Paran\u00e1 , Curitiba 80030-110 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5306-0715","authenticated-orcid":false,"given":"Margaret C S","family":"Boguszewski","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Federal University of Paran\u00e1 , Curitiba 80060-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5096-5722","authenticated-orcid":false,"given":"Philippe","family":"Chanson","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Bic\u00eatre, Service d\u2019Endocrinologie et des Maladies de la Reproduction, Centre de R\u00e9f\u00e9rence des Maladies Rares de l\u2019Hypophyse (HYPO) , Le Kremlin-Bic\u00eatre 94275 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Chatelain","sequence":"additional","affiliation":[{"name":"Coll\u00e8ge of Paediatrics, Universit\u00e9 Claude Bernard Lyon 1, 5, ch de Montlouis , Saint Genis-Laval 69230 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2580-8781","authenticated-orcid":false,"given":"Stefano","family":"Cianfarani","sequence":"additional","affiliation":[{"name":"Department of Systems Medicine, University of Rome \u2018Tor Vergata\u2019 , Rome 00133 ,","place":["Italy"]},{"name":"Endocrinology & Diabetes Unit, \u2018Bambino Ges\u00f9\u2019 Children's Hospital , Rome 00165 ,","place":["Italy"]},{"name":"Department of Women's and Children's Health, Karolinska Institutet , Stockholm 17177 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-6289","authenticated-orcid":false,"given":"Maria","family":"Fleseriu","sequence":"additional","affiliation":[{"name":"Pituitary Center, Departments of Medicine and Neurological Surgery, Oregon Health & Science University , Portland, OR 97239 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4428-8010","authenticated-orcid":false,"given":"Judith","family":"Gebauer","sequence":"additional","affiliation":[{"name":"Department of Oncology, University Cancer Center Leipzig, Leipzig University Hospital , Leipzig 04103 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1523-1536","authenticated-orcid":false,"given":"Adda","family":"Grimberg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["United States"]},{"name":"Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia , Philadelphia, PA 19104 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2508-9588","authenticated-orcid":false,"given":"Ken K Y","family":"Ho","sequence":"additional","affiliation":[{"name":"Sydney Advanced Endocrinology, St. Vincents Hospital and the University of New South Wales , Sydney, NSW 2010 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0145-1917","authenticated-orcid":false,"given":"Andrew R","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Metabolism and Gerontology, Stanford University School of Medicine , Stanford, CA 94305 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3484-8440","authenticated-orcid":false,"given":"Gudmundur","family":"Johannsson","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Department of Endocrinology, Sahlgrenska University Hospital , Gothenburg 413 45 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7408-1526","authenticated-orcid":false,"given":"Jens O L","family":"Jorgensen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine, Aarhus University Hospital , Aarhus 8200 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0534-4350","authenticated-orcid":false,"given":"Anders","family":"Juul","sequence":"additional","affiliation":[{"name":"Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet , Copenhagen 2100 ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, University of Copenhagen , Copenhagen 2200 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1156-4445","authenticated-orcid":false,"given":"Wolfram","family":"Karges","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, RWTH Aachen University Hospital , Aachen 52074 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3365-5375","authenticated-orcid":false,"given":"Jan","family":"Lebl","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, 2nd Faculty of Medicine, Charles University, University Hospital Motol and Homolka , Prague 15006 ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3748-4817","authenticated-orcid":false,"given":"Xiaoping","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan 430030 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7183-5238","authenticated-orcid":false,"given":"Mohamad","family":"Maghnie","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Endocrine Unit, Istituto Giannina Gaslini, IRCCS , Genoa 16147 ,","place":["Italy"]},{"name":"Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa , Genoa 16147 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6705-8579","authenticated-orcid":false,"given":"Aristides","family":"Maniatis","sequence":"additional","affiliation":[{"name":"Rocky Mountain Pediatric Endocrinology , Centennial, CO 80112 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3663-5473","authenticated-orcid":false,"given":"Bradley","family":"Miller","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, University of Minnesota Medical School, M Health Fairview Masonic Children's Hospital , Minneapolis, MN 55454 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7698-0282","authenticated-orcid":false,"given":"Sebastian J C M M","family":"Neggers","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section Endocrinology, and Pituitary Center Rotterdam, Erasmus University Medical Center , Rotterdam 3015 GD ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2639-352X","authenticated-orcid":false,"given":"Michel","family":"Polak","sequence":"additional","affiliation":[{"name":"Service d\u2019Endocrinologie, Gyn\u00e9cologie et Diab\u00e9tologie P\u00e9diatriques, H\u00f4pital Universitaire Necker Enfants Malades Paris, Universit\u00e9 Paris Cit\u00e9, Assistance Publique-H\u00f4pitaux de Paris , Paris 75015 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Radovick","sequence":"additional","affiliation":[{"name":"The Southwest Center for the Advancement of Clinical and Translational Science Innovation, The University of Arizona Health Sciences , Tucson, AZ 85724 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1067-4976","authenticated-orcid":false,"given":"Lars","family":"S\u00e4vendahl","sequence":"additional","affiliation":[{"name":"Department of Women\u00b4s and Children's Health, Karolinska Institutet and Karolinska University Hospital , Stockholm SE-17177 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8050-9127","authenticated-orcid":false,"given":"Junia R O L","family":"Schweizer","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik IV, LMU Klinikum, Ludwig-Maximilians-Universit\u00e4t , Munich 80336 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6831-8520","authenticated-orcid":false,"given":"Paulo F","family":"Collett-Solberg","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro 20550-170 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1950-7325","authenticated-orcid":false,"given":"Adam","family":"Stevens","sequence":"additional","affiliation":[{"name":"Division of Developmental Biology and Medicine, Faculty of Biology, Medicine and Health, University of Manchester, St. Mary's Hospital , Manchester M139WL ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7905-7357","authenticated-orcid":false,"given":"Christian J","family":"Strasburger","sequence":"additional","affiliation":[{"name":"Dept. of Endocrinology and Metabolism, Charit\u00e9 Universitaetsmedizin Berlin Campus Mitte , Berlin 10117 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0006-7726","authenticated-orcid":false,"given":"Christa C","family":"van Bunderen","sequence":"additional","affiliation":[{"name":"Radboud University Medical Center, Department of Internal Medicine, Division of Endocrinology , Radboud University, Nijmegen 6525 GA ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0154-1290","authenticated-orcid":false,"given":"Haim","family":"Werner","sequence":"additional","affiliation":[{"name":"Department of Human Molecular Genetics and Biochemistry, Faculty of Medical and Health Sciences, Tel Aviv University , Tel Aviv 6139001 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9132-6174","authenticated-orcid":false,"given":"Joachim","family":"Woelfle","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Friedrich-Alexander-University (FAU) , Erlangen-Nuremberg, Erlangen 91054 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8169-2728","authenticated-orcid":false,"given":"Kevin C J","family":"Yuen","sequence":"additional","affiliation":[{"name":"Barrow Pituitary Center, Barrow Neurological Institute, Departments of Neuroendocrinology and Neurosurgery, University of Arizona College of Medicine and Creighton University School of Medicine , Phoenix, AZ 85013 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4681-6668","authenticated-orcid":false,"given":"Martin","family":"Bidlingmaier","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik IV, LMU Klinikum, Ludwig-Maximilians-Universit\u00e4t , Munich 80336 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"issue":"6","key":"2026093004245053100_lvag167-B1","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1530\/EJE-16-0111","article-title":"Growth hormone research society perspective on the development of long-acting growth hormone preparations","volume":"174","author":"Christiansen","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2026093004245053100_lvag167-B2","doi-asserted-by":"publisher","first-page":"e1232","DOI":"10.1210\/clinem\/dgae834","article-title":"Long-acting growth hormone therapy in pediatric growth hormone deficiency: a consensus statement","volume":"110","author":"Maniatis","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026093004245053100_lvag167-B3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2147\/DDDT.S315172","article-title":"Developments in the management of growth hormone deficiency: clinical utility of somapacitan","volume":"18","author":"Miller","year":"2024","journal-title":"Drug Des Devel Ther"},{"issue":"6","key":"2026093004245053100_lvag167-B4","doi-asserted-by":"publisher","first-page":"e2121","DOI":"10.1210\/clinem\/dgz149","article-title":"Long-acting growth hormone preparations\u2014current Status and future considerations","volume":"105","author":"Miller","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026093004245053100_lvag167-B5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.637209","article-title":"Usefulness and potential pitfalls of long-acting growth hormone analogs","volume":"12","author":"Yuen","year":"2021","journal-title":"Front Endocrinol"},{"issue":"4","key":"2026093004245053100_lvag167-B6","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.ecl.2025.06.005","article-title":"Long-acting growth hormone preparations","volume":"54","author":"Yuen","year":"2025","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"2026093004245053100_lvag167-B7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/MOP.0000000000001362","article-title":"Update on the use of long-acting growth hormone in children","volume":"36","author":"Boguszewski","year":"2024","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"2026093004245053100_lvag167-B8","doi-asserted-by":"publisher","first-page":"8061","DOI":"10.1038\/s41598-024-58616-4","article-title":"Long-acting growth hormone in the treatment of growth hormone deficiency in children: a systematic literature review and network meta-analysis","volume":"14","author":"Zhu","year":"2024","journal-title":"Sci Rep"},{"key":"2026093004245053100_lvag167-B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106805","article-title":"Efficacy, safety, quality of life, adherence and cost-effectiveness of long-acting growth hormone replacement therapy compared to daily growth hormone in children with growth hormone deficiency: a systematic review and meta-analysis","volume":"193","author":"Mameli","year":"2023","journal-title":"Pharmacol Res"},{"issue":"2","key":"2026093004245053100_lvag167-B10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.6065\/apem.2448202.101","article-title":"Long-acting growth hormones: innovations in treatment and guidance on patient selection in pediatric growth hormone deficiency","volume":"30","author":"Rodaro","year":"2025","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"2026093004245053100_lvag167-B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1718161","article-title":"Delphi-based Spanish consensus on the use of long-acting growth hormone in pediatric growth hormone deficiency: recommendations from the ConverGHe Working Group","volume":"16","author":"Castro-Feij\u00f3o","year":"2025","journal-title":"Front Endocrinol"},{"issue":"8","key":"2026093004245053100_lvag167-B12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1136\/adc.54.8.609","article-title":"Use of growth hormone-gel","volume":"54","author":"Lippe","year":"1979","journal-title":"Arch Dis Child"},{"issue":"1","key":"2026093004245053100_lvag167-B13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s40262-018-0662-5","article-title":"Pharmacokinetics and pharmacodynamics of once-weekly somapacitan in children and adults: supporting dosing rationales with a model-based analysis of three phase I trials","volume":"58","author":"Juul","year":"2019","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"2026093004245053100_lvag167-B14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1210\/clinem\/dgaa775","article-title":"Optimal monitoring of weekly IGF-I levels during growth hormone therapy with once-weekly somapacitan","volume":"106","author":"Kildemoes","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"38","key":"2026093004245053100_lvag167-B15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000034730","article-title":"Investigation of the metabolic and endocrinological differences between daily and weekly growth hormone replacement therapy, somapacitan, in patients with adult growth hormone deficiency: a real-world pilot study","volume":"102","author":"Abe","year":"2023","journal-title":"Medicine."},{"issue":"6","key":"2026093004245053100_lvag167-B16","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.eprac.2025.03.005","article-title":"Efficacy of somapacitan in treatment-fatigue adult patients with growth hormone deficiency previously treated with once-daily growth hormone injections: a 24-week randomized active-controlled trial","volume":"31","author":"Jensterle","year":"2025","journal-title":"Endocr Pract"},{"key":"2026093004245053100_lvag167-B17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2026.1685851","article-title":"Two-year real-world experience with somatrogon in children and adolescents with growth hormone deficiency","volume":"17","author":"Tamaro","year":"2026","journal-title":"Front Endocrinol"},{"key":"2026093004245053100_lvag167-B18","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1438723","article-title":"Use of PEGylated recombinant human growth hormone in Chinese children with growth hormone deficiency: a 24-month follow-up study","volume":"2019","author":"Qiao","year":"2019","journal-title":"Int J Endocrinol"},{"issue":"2","key":"2026093004245053100_lvag167-B19","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.21037\/apm-20-871","article-title":"The impact of pegylated recombinant human growth hormone replacement therapy on glucose and lipid metabolism in children with growth hormone deficiency","volume":"10","author":"Wang","year":"2021","journal-title":"Ann Palliat Med"},{"issue":"1","key":"2026093004245053100_lvag167-B20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s13023-025-03898-8","article-title":"First 100 patients receiving long-acting growth hormone therapy: real-world evaluation from INSIGHTS-GHT registry","volume":"20","author":"Woelfle","year":"2025","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2026093004245053100_lvag167-B21","doi-asserted-by":"publisher","DOI":"10.1155\/ije\/2058589","article-title":"Efficacy and safety of PEGylated recombinant human growth hormone in children with growth hormone deficiency and idiopathic short stature: a real-world cohort study","volume":"2026","author":"Ge","year":"2026","journal-title":"Int J Endocrinol"},{"key":"2026093004245053100_lvag167-B22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.779365","article-title":"Reduced effectiveness and comparable safety in biweekly vs. Weekly PEGylated recombinant human growth hormone for children with growth hormone deficiency: a phase IV non-inferiority threshold targeted trial","volume":"12","author":"Sun","year":"2021","journal-title":"Front Endocrinol"},{"issue":"4","key":"2026093004245053100_lvag167-B23","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1515\/jpem-2021-0735","article-title":"Evaluation of efficacy and safety of long-acting PEGylated recombinant human growth hormone (jintrolong) for patients with growth hormone deficiency","volume":"35","author":"Du","year":"2022","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"10","key":"2026093004245053100_lvag167-B24","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1007\/s00431-024-05719-9","article-title":"Effect of long-acting PEGylated growth hormone for catch-up growth in children with idiopathic short stature: a 2-year real-world retrospective cohort study","volume":"183","author":"Xie","year":"2024","journal-title":"Eur J Pediatr"},{"issue":"3","key":"2026093004245053100_lvag167-B25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1515\/jpem-2024-0496","article-title":"Clinical outcomes of switching to lonapegsomatropin from somatropin for treatment of pediatric growth hormone deficiency","volume":"38","author":"Coyne","year":"2025","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"2","key":"2026093004245053100_lvag167-B26","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4274\/jcrpe.galenos.2025.2025-6-24","article-title":"Real-world efficacy of weekly somatrogon on growth and bone health in pediatric growth hormone deficiency: a 12-month retrospective cohort study","volume":"18","author":"Awad","year":"2026","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"2026093004245053100_lvag167-B27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.955809","article-title":"Short-term efficacy and safety of a lower dose of polyethylene glycol recombinant human growth hormone in children with growth hormone deficiency: a randomized, dose-comparison study","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"2026093004245053100_lvag167-B28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12902-022-01101-8","article-title":"Polyethylene glycol recombinant human growth hormone in Chinese prepubertal slow-growing short children: doses reported in a multicenter real-world study","volume":"22","author":"Chen","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"2026093004245053100_lvag167-B29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.821588","article-title":"PEGylated recombinant human growth hormone jintrolong\u00ae exhibits good long-term safety in cynomolgus monkeys and human pediatric growth hormone deficiency patients","volume":"13","author":"Wu","year":"2022","journal-title":"Front Endocrinol"},{"issue":"28","key":"2026093004245053100_lvag167-B30","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.12998\/wjcc.v11.i28.6715","article-title":"Effects of different doses of long-acting growth hormone in treating children with growth hormone deficiency","volume":"11","author":"Xia","year":"2023","journal-title":"World J Clin Cases"},{"issue":"8","key":"2026093004245053100_lvag167-B31","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1210\/clinem\/dgad039","article-title":"Long-term pegylated GH for children with GH deficiency: a large, prospective, real-world study","volume":"108","author":"Hou","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026093004245053100_lvag167-B32","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00431-025-06268-5","article-title":"Five-year safety and growth response of long-acting PEGylated recombinant human growth hormone in children with growth hormone deficiency-data from CGLS database","volume":"184","author":"Wu","year":"2025","journal-title":"Eur J Pediatr"},{"issue":"2","key":"2026093004245053100_lvag167-B33","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1210\/jc.2011-2234","article-title":"Three-year efficacy and safety of LB03002, a once-weekly sustained-release growth hormone (GH) preparation, in prepubertal children with GH deficiency (GHD)","volume":"97","author":"P\u00e9ter","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026093004245053100_lvag167-B34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1530\/EJE-13-0148","article-title":"Efficacy and safety of LB03002, a once-weekly sustained-release human GH for 12-month treatment in Korean children with GH deficiency","volume":"169","author":"Hwang","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026093004245053100_lvag167-B35","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1210\/jc.2013-2502","article-title":"24-month use of once-weekly GH, LB03002, in prepubertal children with GH deficiency","volume":"99","author":"Khadilkar","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026093004245053100_lvag167-B36","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1210\/jc.2010-2819","article-title":"Effects of once-weekly sustained-release growth hormone: a double-blind, placebo-controlled study in adult growth hormone deficiency","volume":"96","author":"Biller","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026093004245053100_lvag167-B37","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1365-2265.2011.04146.x","article-title":"Effects on metabolic variables after 12-month treatment with a new once-a-week sustained-release recombinant growth hormone (GH: LB03002) in patients with GH deficiency","volume":"76","author":"Roemmler","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2026093004245053100_lvag167-B38","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s11102-012-0422-8","article-title":"12-month effects of once-weekly sustained-release growth hormone treatment in adults with GH deficiency","volume":"16","author":"Biller","year":"2013","journal-title":"Pituitary"},{"issue":"12","key":"2026093004245053100_lvag167-B39","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1210\/clinem\/dgac513","article-title":"Weekly somapacitan is effective and well tolerated in children with GH deficiency: the randomized phase 3 REAL4 trial","volume":"107","author":"Miller","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026093004245053100_lvag167-B40","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1210\/clinem\/dgad394","article-title":"Effective GH replacement with somapacitan in children with GHD: REAL4 2-year results and after switch from daily GH","volume":"108","author":"Miller","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026093004245053100_lvag167-B41","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/cen.15025","article-title":"Effective growth hormone replacement with once-weekly somapacitan in Japanese children with growth hormone deficiency: results from REAL4, a phase 3 clinical trial","volume":"100","author":"Mori","year":"2024","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2026093004245053100_lvag167-B42","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/ejendo\/lvaf096","article-title":"Efficacy, safety, and insulin-like growth factor I of weekly somapacitan in children with growth hormone deficiency: 3-year results from REAL4","volume":"192","author":"Miller","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"2026093004245053100_lvag167-B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000545786","article-title":"Somapacitan is effective and well tolerated in Chinese children with growth hormone deficiency: a randomized controlled phase 3 study","author":"Fu","year":"5, 2025","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"2026093004245053100_lvag167-B44","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1210\/clinem\/dgae616","article-title":"Somapacitan in children born SGA: 52-week efficacy, safety, and IGF-I response results from the phase 2 REAL5 study","volume":"110","author":"Juul","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026093004245053100_lvag167-B45","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/ejendo\/lvag027","article-title":"Somapacitan in children with idiopathic short stature: a randomized controlled phase 3 study","volume":"194","author":"Abuzzahab","year":"2026","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026093004245053100_lvag167-B46","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/ejendo\/lvag041","article-title":"Once-weekly somapacitan in children with noonan syndrome: randomised controlled phase 3 trial","volume":"194","author":"Jorge","year":"2026","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026093004245053100_lvag167-B47","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/ejendo\/lvag021","article-title":"Somapacitan in children born small for gestational age: a randomized controlled phase 3 trial","volume":"194","author":"Linglart","year":"2026","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026093004245053100_lvag167-B48","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaf189","article-title":"Seven-year safety and efficacy of somapacitan in children with GH deficiency: final results from REAL 3","volume":"10","author":"S\u00e4vendahl","year":"2025","journal-title":"J Endocr Soc"},{"issue":"5","key":"2026093004245053100_lvag167-B49","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1530\/EJE-17-1073","article-title":"Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial","volume":"178","author":"Johannsson","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2026093004245053100_lvag167-B50","doi-asserted-by":"publisher","first-page":"e1358","DOI":"10.1210\/clinem\/dgaa049","article-title":"Once-weekly somapacitan is effective and well tolerated in adults with GH deficiency: a randomized phase 3 trial","volume":"105","author":"Johannsson","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026093004245053100_lvag167-B51","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/cen.14273","article-title":"Similar safety and efficacy in previously treated adults with growth hormone deficiency randomized to once-weekly somapacitan or daily growth hormone","volume":"93","author":"Otsuka","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2026093004245053100_lvag167-B52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11102-022-01283-3","article-title":"Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency","volume":"26","author":"Takahashi","year":"2023","journal-title":"Pituitary"},{"key":"2026093004245053100_lvag167-B53","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1534891","article-title":"Efficacy in Japanese adults with growth hormone deficiency receiving weekly somapacitan or daily growth hormone: results from phase 3 REAL 1 trial","volume":"16","author":"Otsuka","year":"2025","journal-title":"Front Endocrinol"},{"issue":"2","key":"2026093004245053100_lvag167-B54","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1530\/EJE-16-0905","article-title":"Long-acting PEGylated recombinant human growth hormone (Jintrolong) for children with growth hormone deficiency: phase II and phase III multicenter, randomized studies","volume":"177","author":"Luo","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026093004245053100_lvag167-B55","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1530\/EJE-22-0449","article-title":"Long-acting PEGylated growth hormone in children with idiopathic short stature","volume":"187","author":"Luo","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"2026093004245053100_lvag167-B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000550510","article-title":"Long-acting PEGylated growth hormone in children with idiopathic short stature: 2-year results","author":"Hou","year":"3, 2026","journal-title":"Horm Res Paediatr"},{"issue":"7","key":"2026093004245053100_lvag167-B57","doi-asserted-by":"publisher","first-page":"e2717","DOI":"10.1210\/clinem\/dgac220","article-title":"Efficacy and safety of weekly somatrogon vs daily somatropin in children with growth hormone deficiency: a phase 3 study","volume":"107","author":"Deal","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026093004245053100_lvag167-B58","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1159\/000524600","article-title":"Efficacy and safety of once-weekly somatrogon compared with once-daily somatropin (genotropin\u00ae) in Japanese children with pediatric growth hormone deficiency: results from a randomized phase 3 study","volume":"95","author":"Horikawa","year":"2022","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"2026093004245053100_lvag167-B59","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/03007995.2023.2290623","article-title":"Health-related quality of life in pre-pubertal children with pediatric growth hormone deficiency: 12-month results from a phase 3 clinical trial of once-weekly somatrogon versus once-daily somatropin","volume":"40","author":"Loftus","year":"2024","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"2026093004245053100_lvag167-B60","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1515\/jpem-2023-0512","article-title":"Post hoc subgroup analysis of Asian children with paediatric GHD from the global phase 3 efficacy and safety study of once-weekly somatrogon vs. once-daily somatropin","volume":"37","author":"Gomez","year":"2024","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"1","key":"2026093004245053100_lvag167-B61","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1507\/endocrj.EJ24-0625","article-title":"Efficacy and safety of once-weekly somatrogon following up to 4 years of treatment in Japanese children with growth hormone deficiency: results from an open-label extension of a phase 3 study","volume":"73","author":"Horikawa","year":"2026","journal-title":"Endocr J"},{"issue":"11","key":"2026093004245053100_lvag167-B62","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1210\/clinem\/dgab529","article-title":"Weekly lonapegsomatropin in treatment-na\u00efve children with growth hormone deficiency: the phase 3 heiGHt trial","volume":"106","author":"Thornton","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026093004245053100_lvag167-B63","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000524003","article-title":"Switching to weekly lonapegsomatropin from daily somatropin in children with growth hormone deficiency: the fliGHt trial","volume":"95","author":"Maniatis","year":"2022","journal-title":"Horm Res Paediatr"},{"issue":"7","key":"2026093004245053100_lvag167-B64","doi-asserted-by":"publisher","first-page":"e2680","DOI":"10.1210\/clinem\/dgac217","article-title":"Safety and efficacy of lonapegsomatropin in children with growth hormone deficiency: enliGHten trial 2-year results","volume":"107","author":"Maniatis","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026093004245053100_lvag167-B65","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1159\/000545064","article-title":"Children with growth hormone deficiency treated with lonapegsomatropin demonstrated sustained height improvements for up to 6 years: enliGHten trial final results","volume":"99","author":"Maniatis","year":"2026","journal-title":"Horm Res Paediatr"},{"key":"2026093004245053100_lvag167-B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000550980","article-title":"Once-weekly lonapegsomatropin was efficacious and well tolerated in Chinese children with growth hormone deficiency: results from a phase 3 randomized trial","author":"Ying","year":"2026","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"2026093004245053100_lvag167-B67","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1210\/clinem\/dgaf680","article-title":"Efficacy and safety of once-weekly lonapegsomatropin in adults with growth hormone deficiency: foresiGHt trial results","volume":"111","author":"Biller","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026093004245053100_lvag167-B68","doi-asserted-by":"publisher","first-page":"e2605","DOI":"10.1210\/clinem\/dgae816","article-title":"A novel Y-shaped pegylated recombinant human growth hormone for children with growth hormone deficiency","volume":"110","author":"Liang","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026093004245053100_lvag167-B69","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1210\/jcem.84.4.5634","article-title":"Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study","volume":"84","author":"Ranke","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026093004245053100_lvag167-B70","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1515\/jpem-2017-0120","article-title":"Individualised growth response optimisation (iGRO) tool: an accessible and easy-to-use growth prediction system to enable treatment optimisation for children treated with growth hormone","volume":"30","author":"Loftus","year":"2017","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"1","key":"2026093004245053100_lvag167-B71","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1472-6947-7-40","article-title":"Models predicting the growth response to growth hormone treatment in short children independent of GH status, birth size and gestational age","volume":"7","author":"Dahlgren","year":"2007","journal-title":"BMC Med Inform Decis Mak"},{"issue":"5","key":"2026093004245053100_lvag167-B72","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000351025","article-title":"Personalized approach to growth hormone treatment: clinical use of growth prediction models","volume":"79","author":"Wit","year":"2013","journal-title":"Horm Res Paediatr"},{"key":"2026093004245053100_lvag167-B73","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2025.1617579","article-title":"Adherence to recombinant human growth hormone therapy in children: influencing factors and clinical implications","volume":"13","author":"Chang","year":"2025","journal-title":"Front Pediatr"},{"issue":"4","key":"2026093004245053100_lvag167-B74","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1159\/000533763","article-title":"Development of a Minimum dataset for the monitoring of recombinant human growth hormone therapy in children with growth hormone deficiency: a GloBE-reg initiative","volume":"97","author":"Chen","year":"2024","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"2026093004245053100_lvag167-B75","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/cen.15298","article-title":"Development of a minimum dataset for the global monitoring of the safety and efficacy of growth hormone replacement in adults with growth hormone deficiency (AGHD)","volume":"103","author":"Chen","year":"2025","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026093004245053100_lvag167-B76","author":"Luo"},{"issue":"6","key":"2026093004245053100_lvag167-B77","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000452150","article-title":"Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency","volume":"86","author":"Grimberg","year":"2016","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"2026093004245053100_lvag167-B78","doi-asserted-by":"publisher","first-page":"P35","DOI":"10.1530\/EJE-21-1186","article-title":"Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement","volume":"186","author":"Boguszewski","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026093004245053100_lvag167-B79","doi-asserted-by":"publisher","first-page":"R126","DOI":"10.1530\/EC-18-0047","article-title":"Growth hormone research society perspective on biomarkers of GH action in children and adults","volume":"7","author":"Johannsson","year":"2018","journal-title":"Endocr Connect"},{"issue":"10444","key":"2026093004245053100_lvag167-B80","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/S0140-6736(24)00342-8","article-title":"Hypopituitarism","volume":"403","author":"Fleseriu","year":"2024","journal-title":"Lancet"},{"key":"2026093004245053100_lvag167-B81","author":"GloBE-Reg"},{"issue":"6","key":"2026093004245053100_lvag167-B82","doi-asserted-by":"publisher","first-page":"592","DOI":"10.20945\/2359-3997000000189","article-title":"Personalized approach to growth hormone replacement in adults","volume":"63","author":"van Bunderen","year":"2019","journal-title":"Arch Endocrinol Metab"},{"key":"2026093004245053100_lvag167-B83","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1040046","article-title":"Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparation","volume":"13","author":"Bidlingmaier","year":"2022","journal-title":"Front Endocrinol"},{"key":"2026093004245053100_lvag167-B84","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.2147\/DDDT.S336285","article-title":"Spotlight on lonapegsomatropin once-weekly injection and its potential in the treatment of growth hormone deficiency in pediatric patients","volume":"16","author":"Miller","year":"2022","journal-title":"Drug Des Devel Ther"},{"key":"2026093004245053100_lvag167-B85"},{"issue":"10","key":"2026093004245053100_lvag167-B86","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac117","article-title":"Treatment burden of weekly somatrogon vs daily somatropin in children with growth hormone deficiency: a randomized study","volume":"6","author":"Maniatis","year":"2022","journal-title":"J Endocr Soc"},{"key":"2026093004245053100_lvag167-B87","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.galenos.2025.2025-10-16","article-title":"Reversible injection-site lipoatrophy induced by long-acting growth hormone (somatrogon) in pediatric growth hormone deficiency: a case series","author":"\u015een K\u00fc\u00e7\u00fck","year":"20, 2025","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"5","key":"2026093004245053100_lvag167-B88","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s11102-024-01440-w","article-title":"Somapacitan-induced reversible lipoatrophy in an adult woman with hypopituitarism","volume":"27","author":"Rakusa","year":"2024","journal-title":"Pituitary"},{"issue":"1","key":"2026093004245053100_lvag167-B89","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1515\/jpem.1999.12.1.95","article-title":"Localized lipoatrophy due to recombinant growth hormone therapy in a child with 6.7 kilobase gene deletion isolated growth hormone deficiency","volume":"12","author":"B\u00fcy\u00fckgebiz","year":"1999","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"5","key":"2026093004245053100_lvag167-B90","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1159\/000530522","article-title":"Weekly growth hormone (lonapegsomatropin) causes severe transient hyperglycemia in a child with obesity","volume":"96","author":"Alkhatib","year":"2023","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"2026093004245053100_lvag167-B91","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1210\/jcem-61-6-1152","article-title":"Effects of hypopituitarism and growth hormone replacement therapy on the production and utilization of glucose in childhood","volume":"61","author":"Bougneres","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026093004245053100_lvag167-B92","doi-asserted-by":"publisher","first-page":"408","DOI":"10.21037\/tp.2017.10.05","article-title":"Approach to hypoglycemia in infants and children","volume":"6","author":"Gandhi","year":"2017","journal-title":"Transl Pediatr"},{"issue":"3","key":"2026093004245053100_lvag167-B93","doi-asserted-by":"publisher","first-page":"145","DOI":"10.6065\/apem.2017.22.3.145","article-title":"Effects of growth hormone on glucose metabolism and insulin resistance in human","volume":"22","author":"Kim","year":"2017","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"5","key":"2026093004245053100_lvag167-B94","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1210\/clinem\/dgag093","article-title":"Long-acting growth hormone for treating growth hormone deficiency in children: a meta-analysis of randomized controlled trials focusing on changes in body mass Index","volume":"111","author":"Levaillant","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026093004245053100_lvag167-B95","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1530\/EJE-16-0748","article-title":"MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a phase 2 study in growth hormone-deficient adults","volume":"176","author":"Strasburger","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026093004245053100_lvag167-B96","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaf193","article-title":"Distinct glucose profiles with daily and weekly growth hormone therapy revealed by continuous glucose monitoring","volume":"10","author":"Taguchi","year":"2025","journal-title":"J Endocr Soc"},{"issue":"11","key":"2026093004245053100_lvag167-B97","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1007\/s40618-025-02664-8","article-title":"Reduced high-sensitivity C-reactive protein levels following weekly somapacitan in adults with growth hormone deficiency: a prospective pilot study","volume":"48","author":"Seki","year":"2025","journal-title":"J Endocrinol Invest"},{"issue":"7","key":"2026093004245053100_lvag167-B98","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1210\/clinem\/dgac199","article-title":"Long-term safety of growth hormone in adults with growth hormone deficiency: overview of 15 809 GH-treated patients","volume":"107","author":"Johannsson","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026093004245053100_lvag167-B99","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1210\/jc.2018-01175","article-title":"Hypothalamic\u2013pituitary and growth disorders in survivors of childhood cancer: an endocrine society* clinical practice guideline","volume":"103","author":"Sklar","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026093004245053100_lvag167-B100","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1210\/jc.2015-1002","article-title":"Risk of neoplasia in pediatric patients receiving growth hormone therapy\u2013A report from the pediatric endocrine society drug and therapeutics committee","volume":"100","author":"Raman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026093004245053100_lvag167-B101","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.4158\/GL-2019-0405","article-title":"AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE","volume":"25","author":"Yuen","year":"2019","journal-title":"Endocr Pract"},{"issue":"2","key":"2026093004245053100_lvag167-B102","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3803\/EnM.2020.35.2.272","article-title":"Diagnosis and treatment of growth hormone deficiency: a position statement from Korean endocrine society and Korean society of pediatric endocrinology","volume":"35","author":"Kim","year":"2020","journal-title":"Endocrinol Metab"},{"issue":"3","key":"2026093004245053100_lvag167-B103","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaf219","article-title":"Patient and caregiver preferences for once-weekly injection devices for the treatment of growth hormone deficiency","volume":"10","author":"Chen","year":"2026","journal-title":"J Endocr Soc"},{"issue":"1","key":"2026093004245053100_lvag167-B104","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1530\/EJE-21-1167","article-title":"Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency","volume":"187","author":"Kildemoes","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2026093004245053100_lvag167-B105","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaf001","article-title":"IGF-1 Assessment during weekly somatrogon treatment in pediatric patients with GH deficiency","volume":"9","author":"Nayak","year":"2025","journal-title":"J Endocr Soc"},{"issue":"1","key":"2026093004245053100_lvag167-B106","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab168","article-title":"Average IGF-1 prediction for once-weekly lonapegsomatropin in children with growth hormone deficiency","volume":"6","author":"Lin","year":"2022","journal-title":"J Endocr Soc"},{"issue":"11","key":"2026093004245053100_lvag167-B107","doi-asserted-by":"publisher","first-page":"bvad115","DOI":"10.1210\/jendso\/bvad115","article-title":"Model-based analysis of IGF-I response, dosing, and monitoring for once-weekly somapacitan in children with GH deficiency","volume":"7","author":"Kildemoes","year":"2023","journal-title":"J Endocr Soc"},{"issue":"9","key":"2026093004245053100_lvag167-B108","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1210\/jc.2016-1257","article-title":"Reference values for IGF-I serum concentrations: comparison of six immunoassays","volume":"101","author":"Chanson","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026093004245053100_lvag167-B109","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1210\/jc.2017-00202","article-title":"Classification of patients with GH disorders may vary according to the IGF-I assay","volume":"102","author":"Mavromati","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026093004245053100_lvag167-B110","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1373\/clinchem.2010.150631","article-title":"Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays","volume":"57","author":"Clemmons","year":"2011","journal-title":"Clin Chem"},{"issue":"1","key":"2026093004245053100_lvag167-B111","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1093\/ejendo\/lvae065","article-title":"IGF-I assay methods and biologic variability: evaluation of acromegaly treatment response","volume":"191","author":"Clemmons","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"2026093004245053100_lvag167-B112","author":"SAFE-survivors"},{"issue":"5","key":"2026093004245053100_lvag167-B113","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1210\/clinem\/dgad717","article-title":"Gene expression signatures predict first-year response to somapacitan treatment in children with growth hormone deficiency","volume":"109","author":"Garner","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026093004245053100_lvag167-B114","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1056\/NEJMsr1809937","article-title":"The \u201call of US\u201d research program","volume":"381","author":"All of Us Research Program Investigators","year":"2019","journal-title":"N Engl J Med"},{"issue":"7726","key":"2026093004245053100_lvag167-B115","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvag167\/70888905\/lvag167.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/3\/R73\/70888905\/lvag167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/3\/R73\/70888905\/lvag167.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:25:00Z","timestamp":1790756700000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/195\/3\/R73\/8777315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":115,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvag167","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,28]]}}}